209 related articles for article (PubMed ID: 21666151)
1. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
[TBL] [Abstract][Full Text] [Related]
2. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
[TBL] [Abstract][Full Text] [Related]
3. Measles control in Sub-Saharan Africa: South Africa as a case study.
Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
[TBL] [Abstract][Full Text] [Related]
4. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
[TBL] [Abstract][Full Text] [Related]
5. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
6. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of an intervention project engaging Traditional and Religious Leaders to improve uptake of childhood immunization in southern Nigeria.
Oyo-Ita AE; Hanlon P; Nwankwo O; Bosch-Capblanch X; Arikpo D; Esu E; Auer C; Meremikwu M
PLoS One; 2021; 16(9):e0257277. PubMed ID: 34529714
[TBL] [Abstract][Full Text] [Related]
8. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.
Peter KB; Ademola AS; Oyeku OA
Afr Health Sci; 2014 Mar; 14(1):131-5. PubMed ID: 26060469
[TBL] [Abstract][Full Text] [Related]
9. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
[TBL] [Abstract][Full Text] [Related]
10. Progress Toward Measles Elimination - European Region, 2009-2018.
Zimmerman LA; Muscat M; Singh S; Ben Mamou M; Jankovic D; Datta S; Alexander JP; Goodson JL; O'Connor P
MMWR Morb Mortal Wkly Rep; 2019 May; 68(17):396-401. PubMed ID: 31048675
[TBL] [Abstract][Full Text] [Related]
11. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
Bauch CT; Szusz E; Garrison LP
Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
[TBL] [Abstract][Full Text] [Related]
12. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
[TBL] [Abstract][Full Text] [Related]
14. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
Thompson KM; Badizadegan ND
Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
[TBL] [Abstract][Full Text] [Related]
15. Maintaining high rates of measles immunization in Africa.
Lessler J; Moss WJ; Lowther SA; Cummings DA
Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
[TBL] [Abstract][Full Text] [Related]
16. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
[TBL] [Abstract][Full Text] [Related]
17. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
[TBL] [Abstract][Full Text] [Related]
18. International measles incidence and immunization coverage.
Hall R; Jolley D
J Infect Dis; 2011 Jul; 204 Suppl 1():S158-63. PubMed ID: 21666157
[TBL] [Abstract][Full Text] [Related]
19. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
[TBL] [Abstract][Full Text] [Related]
20. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.
Verguet S; Jassat W; Bertram MY; Tollman SM; Murray CJ; Jamison DT; Hofman KJ
Glob Health Action; 2013 Mar; 6():1-9. PubMed ID: 23458088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]